PD-L1 and LAG3 Expression in Hepatocellular Carcinoma Associated with HCV and Steatohepatitis

被引：0
|
作者：
Xing, Dongmei
Luan, Lan
Zhu, Qingfeng
Gani, Faiz
Pawlik, Timothy
Taube, Janis M.
Anders, Robert A.
机构：
[1] Weill Cornell Med, New York, NY USA
[2] Johns Hopkins Univ, Baltimore, MD USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1707
引用
收藏
页码：426A / 426A
页数：1
相关论文
共 50 条
  • [41] POTENTIAL AS BIOMARKERS OF SOLUBLE PD-1 AND PD-L1 IN HEPATOCELLULAR CARCINOMA
    Kanzaki, Hiroaki
    Chiba, Tetsuhiro
    Kato, Naoya
    HEPATOLOGY, 2019, 70 : 1218A - 1218A
  • [42] Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma
    Gong, Xue-Qin
    Liu, Ning
    Tao, Yun-Yun
    Li, Li
    Li, Zu-Mao
    Yang, Lin
    Zhang, Xiao-Ming
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [43] Characterizing PD-L1/PD-1 expression in hepatocellular carcinoma and implications on postresection treatment response.
    Farha, Mark
    Green, Michael
    El Naga, Issam
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma
    Xue-Qin Gong
    Ning Liu
    Yun-Yun Tao
    Li Li
    Zu-Mao Li
    Lin Yang
    Xiao-Ming Zhang
    Scientific Reports, 13
  • [45] M1-like macrophages induce PD-L1 expression in hepatocellular carcinoma cells
    Zong, Z.
    Zou, J.
    Mao, R.
    Ma, C.
    Li, N.
    Shi, Y.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 105 - 105
  • [46] Synergistic effect of IFN-γ and IL-1β on PD-L1 expression in hepatocellular carcinoma
    Numata, Yasunao
    Akutsu, Noriyuki
    Ishigami, Keisuke
    Koide, Hideyuki
    Wagatsuma, Kohei
    Motoya, Masayo
    Sasaki, Shigeru
    Nakase, Hiroshi
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2022, 30
  • [47] Tumor-stroma ratio predicts prognosis and PD-L1 expression in hepatocellular carcinoma
    Wang, Dong
    Luo, Jia
    Tao, YiMing
    BMC CANCER, 2023, 23 (01)
  • [48] Expression and Prognostic Value of Tumor-Infiltrating Lymphocytes and PD-L1 in Hepatocellular Carcinoma
    Nie, Hanxiao
    He, Tao
    Wang, Li
    Zhang, Ling
    ONCOTARGETS AND THERAPY, 2021, 14 : 1377 - 1385
  • [49] Expression and clinical significance of PD-1, PD-L1 and PARP-1 in hepatocellular carcinoma and paracancerous tissues
    Yang, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1898 - 1898
  • [50] Expression of PSMA in Tumor-Associated Vasculature Predicts Poorer Survival in Patients With Hepatocellular Carcinoma and Is Likely Associated With PD-L1
    Li, Rena X.
    Hao, Yansheng
    Ettel, Mark
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2024, 32 (07) : 1248 - 1255
12345